Mayport LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
993
-12
-1% -$12.3K 0.18% 48
2026
Q1
$924K Buy
1,005
+38
+4% +$38.5K 0.17% 49
2025
Q4
$1.04M Buy
967
+17
+2% +$16.3K 0.21% 43
2025
Q3
$725K Buy
950
+51
+6% +$38K 0.16% 45
2025
Q2
$700K Buy
899
+7
+0.8% +$5.44K 0.17% 47
2025
Q1
$737K Buy
892
+279
+46% +$232K 0.2% 41
2024
Q4
$473K Buy
613
+4
+0.7% +$3.31K 0.14% 52
2024
Q3
$540K Hold
609
0.17% 45
2024
Q2
$551K Hold
609
0.2% 46
2024
Q1
$474K Hold
609
0.18% 50
2023
Q4
$355K Hold
609
0.16% 61
2023
Q3
$327K Hold
609
0.18% 50
2023
Q2
$286K Hold
609
0.16% 56
2023
Q1
$209K Hold
609
0.13% 64
2022
Q4
$223K Buy
+609
New +$216K 0.17% 52

Other funds holding LLY

Mayport LLC's LLY Position: Q2 2026 in Review

Mayport LLC reduced its Eli Lilly (LLY) stake by 1.2% in Q2 2026, selling an estimated $12.3K and leaving 993 shares worth $1.19M. The position accounts for 0.18% of the portfolio, ranked #48.

Mayport LLC first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mayport LLC held 993 shares of Eli Lilly worth $1.19M as of Q2 2026.
  • Mayport LLC sold 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 0.18% of Mayport LLC's portfolio in Q2 2026, its #48 holding.
  • Mayport LLC first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mayport LLC's 13F filing for Q2 2026, filed 7 Aug 2026.